![Lori M. Waldron Life Sciences Practice Attorney Sills Cummis & Gross Law Firm](/sites/default/files/styles/author_profile/public/2023-10/Waldron-Lori_150x200.jpg?itok=1OLvwKlM)
Lori M. Waldron is Co-Chair of the Sills Cummis & Gross Life Sciences Practice Group. Her practice focuses on the representation of both emerging growth and well-established public and private companies in sophisticated business transactions, with a particular emphasis on the life sciences and biotech industries. Ms. Waldron has extensive experience representing clients through all phases of their business cycles and advising them how to best take advantage of varying business opportunities, whether arising in the ordinary course of business or as an extraordinary matter. Her regular practice includes counseling her clients in connection with start-up matters (including formation issues, corporate debt and equity structure, shareholder arrangements and officer/director/employee compensation issues), angel and venture capital financings, private equity and debt investments, joint ventures and other strategic and collaborative alliances, and manufacturing and supply arrangements. Ms. Waldron also advises her clients in connection with a wide variety of complex business purchases, combinations and divestitures (including mergers, acquisitions, stock and asset sales, spin-offs, license agreements and sublicense arrangements) and general corporate matters.
More Legal and Business Bylines From Lori M. Waldron
- Second Tranche Paycheck Protection Program Funds Authorized by the Consolidated Appropriations Act - (Posted On Thursday, January 07, 2021)
- SBA Releases Procedural Notice for PPP Borrowers Engaging in M&A Transactions - (Posted On Monday, October 12, 2020)
- Federal Reserve Announces Updated Guidance Regarding Main Street Lending Program for Small and Mid-sized Businesses - (Posted On Friday, June 19, 2020)
- Paycheck Protection Program Flexibility Act Signed into Law - (Posted On Wednesday, June 17, 2020)
- SBA Releases Loan Forgiveness and Other Guidance - (Posted On Wednesday, June 03, 2020)
- UPDATED May 8, 2020- Timely Economic Relief Information: CARES Act, New York, and New Jersey Specific Information - (Posted On Friday, May 08, 2020)
- Life Sciences: Protecting the Crown Jewels - (Posted On Thursday, February 19, 2015)
- Buyer Beware: Important “Supply” Issues For Life Science Companies - (Posted On Wednesday, July 03, 2013)
- Five Traps for the Unwary Licensee - (Posted On Sunday, June 03, 2012)
- Six Important Strategies To Reduce The Royalty Burden For A Pharmaceutical Product - (Posted On Monday, October 10, 2011)
The National Law Review recognizes Sills, Cummis & Gross as a Go-To Thought Leader for the firm’s COVID-19 coverage focusing on pandemic legislation relevant to the New York and New Jersey areas. Sills attorney – authors kept NLR readers apprised of sick leave rules, workers compensation coverage for essential workers, CARES act updates, executive orders, regional regulations and workplace restrictions. The following Sills, Cummis & Gross New York & New Jersey Coronavirus authors were exceptionally popular with the NLR readers: Grace A. Byrd, Brian A. Haskel, Jill Turner Lever, David I. Rosen, Alan E. Sherman, Jason L. Sobel and Lori M. Waldron.